GRNTI 76.33 Гигиена и эпидемиология
GRNTI 76.03 Медико-биологические дисциплины
OKSO 31.06.2001 Клиническая медицина
OKSO 31.08.08 Радиология
OKSO 32.08.12 Эпидемиология
OKSO 14.04.02 Ядерные физика и технологии
BBK 534 Общая диагностика
BBK 51 Социальная гигиена и организация здравоохранения. Гигиена. Эпидемиология
TBK 5712 Медицинская биология. Гистология
TBK 5734 Медицинская радиология и рентгенология
TBK 6212 Радиоактивные элементы и изотопы. Радиохимия
TBK 5708 Гигиена и санитария. Эпидемиология. Медицинская экология
In 2018 in Russian Federation more than 500 thousand new cases of cancer were found, including 8000 cases with malignant tumors of esophagus and more than 30 % of patients have the IV stage. Esophageal cancer takes the 6-th place in death causes connected to cancer in the world and it is still one of the main global problems in medical care. Oncologists face the problem of the most difficult choice in treatment tactics for spread stages of disease. In this situation it is recommended to provide combined treatment (surgery, neoadjuvant and adjuvant chemotherapy). Definitive radiotherapy or chemoradiotherapy (without surgery) is used for patients with unrespectable esophageal tumor. In this article we present clinical case of successful treatment of a patient with metastatic esophageal cancer. The patient got chemoradiotherapy in 2017 and after control checkup in November 2019 remission was registered. After provided treatment stopping of pain syndrome and dysphagia, food passage through esophagus was restored. The patient notes good life quality, he is physically active and socially adapted.
esophageal cancer, radiotherapy, chemoradiotherapy, palliative treatment
1. Kaprin A.D., Starinskiy V.V., Petrova G.V. Sostoyanie onkologicheskoy pomoschi naseleniyu Rossii v 2018 g. M.: MNIOI im. P.A. Gercena. 2019. S. 27-31.
2. Bray F., Ferlay J., Soerjomataram I., et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA Cancer J. Clin. 2018. V.68, No. 6. P.394-424.
3. Smyth E.C., Lagergren J., Fitzgerald R.C., et al. Oesophageal Cancer // Nature Reviews Disease Primers. 2017. No. 3. P. 17-48.
4. Alsop B.R., Sharm P. Esophageal Cancer // Gastroenterology Clinics of North America. 2016. V.45, No. 3. P. 399-412.
5. Tryakin A.A., Besova N.S., Volkov N.M. i dr. Prakticheskie rekomendacii po lekarstvennomu lecheniyu raka pischevoda i pischevodno-zheludochnogo perehoda // Zlokachestvennye opuholi: Prakticheskie rekomendacii RUSSCO. 2018. T.8. S. 260-272.
6. Jennifer E. Tham, Benjamin Tharian, Patrick B. Allen, et al. Oesophageal Stents for Potentially Curable Oesophageal Cancer-A Bridge to Surgery? // Ulster Medical Journal. 2019. V.88, No. 1. P. 10-14.
7. Hulshof M.C.C.M., van Laarhoven H.W.M. Chemoradiotherapy in Tumours of the Oesophagus and Gastro-Oesophageal Junction // Best Practice & Research Clinical Gastroenterology. 2016. No. 30. P. 551-563.
8. Greally M., Ilson D.H. Neoadjuvant Therapy for Esophageal Cancer: who, when, and what? // Cancer. 2018. No. 124. P. 4276-4278.
